Updates on Access Pharma, BioSphere Medical, CryoLife, NeoPharm [View article]
with the capital raise fears, AccessPharma will likely remain contained. They need a lot more cash to conduct business. Partners are likely to attempt to squeeze knowing Access is desperate for cash.
Interview with Access Pharma CEO: Updates and Outlook [View article]
All the info sounds good, but almost too good. The CEO seems too busy telling the story to the media instead via the financials. We'll be watching, but concerned to step in at this point.
Updates on Access Pharma, BioSphere Medical, CryoLife, NeoPharm [View article]
Interview with Access Pharma CEO: Updates and Outlook [View article]
Unlocking Access Pharma's Value: Key Upcoming Catalysts [View article]